Pacira Pharmaceuticals buy HC Wainwright
Start price
06.11.23
/
50%
€28.40
Target price
06.11.24
€53.07
Performance (%)
-2.82%
Price
09.05.24
€27.00
Summary
This prediction is currently active. With a performance of -2.82%, the BUY prediction by HC_Wainwright is trending in the wrong direction. This prediction currently runs until 06.11.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | -3.200% | -3.200% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at HC Wainwright from $63.00 to $57.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
2.99%
09.05.24
09.05.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
5.34%
09.05.24
09.05.24